Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise study seeks to unlock eating disorder clues

NCT ID NCT06213883

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 2 times

Summary

This study looked at how exercise changes body image, mood, and certain blood markers in young women aged 16-25 with restrictive eating disorders. Researchers measured responses during lab-based exercise and rest. The goal is to better understand driven exercise—a common symptom—and lay groundwork for more targeted treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

74 people

The number who actually took part.

Started

Nov 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 25 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 16-25 * ED participants must meet full criteria for DSM-5 restrictive-spectrum eating disorders characterized by weight and shape concern, I.e., anorexia nervosa (AN); mild, moderate, or in partial remission), atypical AN, and OSFED -AN type only) * ED participants must be medically stable, and suitable for outpatient treatment * Biological Females, Assigned Female at birth * English Speaking Exclusion Criteria: * Those with a medical condition that precludes exercise (e.g., severe asthma) will be excluded for any contraindications * Biological Males, Assigned Male at birth * BMI less than 16 (over 18 years) or less than 75% expected body weight (under 18 years) * Reported intake on Eating Disorder Examination \<1000kcal daily * Current purging \>1x per day * Current regular episodes of objective binge eating (\>1x/wk) * Current self-report of loss-of control eating per the Eating Disorders Examination Interview * ED related hospitalization, partial hospitalization, or residential treatment in the past month * Any endorsed medical concerns related to physical activity (as probed in the phone screening questions regarding cardiovascular, pulmonary, or metabolic disease). * Major medical disorders (e.g., cancer, AIDS) * Physical discomfort or difficulty with blood draws * Psychotic disorders * Intellectual disabilities * Developmental disorders * Active substance use disorder * Current suicidal risk per the Ask Suicide Screening Questionnaire * Pregnancy * Psychiatric medications that have not been stable for at least 4 weeks * Acute sedatives / pain killers (e.g., benzodiazepines, opioids) and prescription stimulants (e.g., methylphenidate, amphetamines) are not permitted for the full day prior to the laboratory session. The noted short-term medication holds only apply to subjects taking the noted medications in cases used to treat ADHD or other psychiatric conditions * Resting heart rate \<50 beats per minute (assessed at screening visit) * Low blood pressure (\<90/60), (assessed at screening visit) * Daily cannabis use * History of light headedness or fainting during blood draws or physical activity * History of chest pain during physical activity * Bone, joint, cardiac, pulmonary, metabolic, or other medical conditions that may be worsened by physical activity (e.g., COPD, diabetes, hypertension) that are not currently addressed via medication or lifestyle change. * Physical disabilities that prohibit task performance (such as blindness or deafness) * Any other condition that the investigator believes might put the participant at risk for negative outcomes * Individuals with a restrictive eating disorder presentation that does not include weight and shape concern (ARFID) or that has primary binge eating (bulimia nervosa) * Indication of health risk associated with exercise on the Physical Activity Readiness Questionnaire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorexia nervosa eating disorder Feeding and Eating Disorders Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California San Francisco

    San Francisco, California, 94158, United States

  • University of Wisconsin-Madison

    Madison, Wisconsin, 53719, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.